Gefitinib 250.00 mg

GEFICAD 250 is a medication that contains 250.00mg of Gefitinib as its active ingredient. It is commonly used in the treatment of non-small cell lung cancer (NSCLC) that is locally advanced or has spread to other parts of the body. GEFICAD 250 belongs to a class of medications known as tyrosine kinase inhibitors, which work by blocking the action of certain proteins that are involved in the growth and spread of cancer cells. It is prescribed by a doctor and should be taken under their supervision.

Take GEFICAD 250 as prescribed by your doctor. It is usually taken on an empty stomach, at least one hour before or two hours after meals. It is important to swallow the tablet whole with a glass of water, without crushing or chewing it. The dosage and duration of treatment will be determined by your doctor based on your specific condition.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.